Idiopathic Interstitial Pneumonia

It is important to consider interstitial lung disease subtypes when applying progressive fibrosing ILD criteria, researchers concluded in an analysis published in European Respiratory Journal.

Among patients with idiopathic interstitial pneumonia associated with pulmonary hypertension, treatment with riociguat was linked to an increase in adverse events with no significant evidence of benefit, according to the RISE-IIP trial.